2019.06.03PDF( 51KB)
Notification of Transfer of Marketing and Manufacturing Approval and Distribution Rights for the transdermal follicle and luteinizing hormone product "Menoaid® Combipatch"
2019.05.24PDF( 85KB)
Notification of the results of the Phase II clinical study of HP-5070 in Japan (a transdermal drug for the treatment of primary local hyperhidrosis)
2019.05.24PDF( 85KB)
Notification of the results of Phase III clinical study of HP-3150 in Japan for "cancer pain" (an analgesic transdermal drug containing NSAIDs)
2019.05.17PDF(334KB)
Salonpas® Named the World's No. 1 OTC Topical Analgesic Patch Brand for the Third Consecutive Year
2019.04.10
FY02/2019 Q4 Results Earnings Release Presentation